Results 191 to 200 of about 74,231 (262)

Induction therapy with interferon plus ribavirin for naïve patients with chronic hepatitis C: A preliminary report

, 2000
Luiz C. da Silva, Flair José Carrilho, J.E.M. Medeiros-Filho, Lúcio C. Anjos, João Renato Rebello Pinho, Antônio Atílio Laudanna   +5 more
openalex   +1 more source

Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks. [PDF]

J Virol
Fedorchenko SV, Klimenko Z, Martynovich T, Solianyk I, Suprunenko T.   +4 more
europepmc   +1 more source

The Prevalence, Risk Factors, and Outcomes of Hepatitis E Virus Infection in Solid Organ Transplant Recipients in a Highly Endemic Area of Italy. [PDF]

Viruses
Binda B, Picchi G, Bruni R, Di Gasbarro A, Madonna E, Villano U, Pisani G, Carocci A, Marcantonio C, Montali F, Panarese A, Pisani F, Ciccaglione AR, Spada E.   +13 more
europepmc   +1 more source

The Ribavirin Analog ICN 17261 Demonstrates Reduced Toxicity and Antiviral Effects with Retention of both Immunomodulatory Activity and Reduction of Hepatitis-Induced Serum Alanine Aminotransferase Levels

, 2000
Robert C. Tam, Kanda S. Ramasamy, Josie Bard, Bharati Pai, Charmaine Lim, D R Averett   +5 more
openalex   +1 more source

Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab. [PDF]

J Viral Hepat
Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D, Kanellis G, Panopoulou M, Mitroulis I, Ritis K, Skendros P, Kouklakis G.   +11 more
europepmc   +1 more source

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]

BMJ Open Gastroenterol
Mustafa A, Davlidova S, Abidi SH, Begimbetova D, Heimer R, Vermund SH, Ali S.   +6 more
europepmc   +1 more source

Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals. [PDF]

NPJ Antimicrob Resist
Aw DZH, Zhang DX, Vignuzzi M.
europepmc   +1 more source

The efficacy of an interferon dose escalation scheme, combined with ribavirin, for the initial treatment of hepatitis C: An interim analysis of early and end of treatment virologic response

, 2000
Victor J. Navarro, Robert Leventhal, John Polio, Nelson Bonheim, Tarun Gupta, Joseph Fiorito, Kathleen Tummillo   +6 more
openalex   +1 more source

Elimination of hepatitis C in the Middle East: a narrative review of the efficacy of direct-acting antiviral therapies. [PDF]

Transl Gastroenterol Hepatol
Coxeter-Smith C, Gaglani RB, Ingram RD, Kidd OT, Kumar AS, Alhadad A, Alrubaiy L.   +6 more
europepmc   +1 more source

Combination therapy with interferon and ribavirin in naive patients of chronic hepatitis C in India: role of genotype and stage of liver disease

, 2000
G. Choudhuri
openalex   +1 more source